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CD9 Is Critical for Cutaneous Wound Healing
through JNK Signaling
Jiaping Zhang1,2, Jianda Dong1,3, Hua Gu4,5, Sidney Yu1, Xiaohu Zhang1, Yulin Gou1, Wenming Xu1,
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Cutaneous injury triggers a cascade of signaling events essential for wound re-epithelialization. CD9, a cell-
surface protein, has been implicated in a number of cellular processes by coupling to intracellular signaling;
however, its exact role in wound healing remains unidentified. We reported that CD9 was downregulated in
migrating epidermis, and reelevated to basal level when re-epithelialization was completed. Although low level
of CD9 appears to be required for normal wound healing, a significant healing delay was found in CD9-null
mice, with wounds gaping wider on day 5 and day 7 post wounding. Further analysis showed that re-
epithelialization was adversely affected in CD9-null mice, due to impaired migration of epidermis. Notably, CD9
deficiency caused a persistent enhancement of C-JUN NH2 terminal kinase (JNK) signaling primarily in
migrating epidermis with abnormal elevation of matrix metalloproteinase (MMP)-9 detected in CD9-null
wounds, leading to excessive degradation of type IV collagen, and thus a defective basement membrane at
the wound site. JNK suppression reduced MMP-9 production and therefore ameliorated the healing delay with
the appearance of significantly elongated migrating epidermis in CD9-null mice. Our study demonstrated the
importance of CD9 in wound re-epithelialization, linking this molecule directly to basement membrane
formation and epidermal migration through participating in the regulation of the JNK/MMP-9 pathway.
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INTRODUCTION
CD9, a 24 kDa cell-surface protein belonging to the tetra-
spanins family, has been implicated in a wide variety of
cellular biological functions such as platelet activation,
fertilization, tumor metastasis, cell migration, and survival
(Saito et al., 2006; Deissler et al., 2007; Fa´bryova´ and Simon,
2009; Zo¨ller, 2009). Although the mechanisms for the
functional diversity of CD9 are not fully understood, recent
studies suggest that it might be closely related to its capacity to
couple specific intracellular signaling depending on cell types
or stimulus. CD9, similar to other tetraspanins, generally does
not function as a cell-surface receptor, but serves as an
organizer of multimolecular complexes and affects their
downstream signaling (Hemler, 2005). For example, associa-
tion of CD9 with transmembrane transforming growth factor-a
regulates transforming growth factor-a-induced activation of
EGFR signaling, resulting in altered cell proliferation (Shi et al.,
2000). In ovary cells, CD9 regulates integrin b1 activation and
enhances cell motility through PI-3K/Akt pathway (Kotha
et al., 2008). CD9 can also regulate the intracellular signaling
at transcription level (Huang et al., 2004).
Wound triggers a cascade of signaling events to ensure the
normal re-epithelialization, of which the C-JUN NH2
terminal kinase (JNK) signaling has been shown to be critical.
JNK is a member of mitogen-activated protein superfamily
kinases that stand at the fulcrum of many signal transduction
pathways. This pathway was originally identified as the
mechanism by which cells respond to extracellular stress.
Recent studies suggest that it is also important in wound
healing. Inhibition of JNK impairs keratinocyte migration and
the healing of an in vitro wound, but promotes its
differentiation (Gazel et al., 2006). Mice deficient in MEKK1,
a kinase upstream of JNK, show a significant healing delay
due to impaired activation of JNK and reduced expression
of genes involved in extracellular matrix (ECM) homeo-
stasis (Deng et al., 2006). Although these studies suggest an
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essential role for JNK activation in the healing process, the
question of how JNK activity and its regulation contribute to
the wound-healing process in vivo remains elusive.
CD9 has been known to express in skin epidermis for more
than a decade (Sincock et al., 1997); whether it plays a role in
cutaneous wound healing has not yet been addressed.
Interestingly, CD9 is downregulated in epithelial tumors
and inversely correlated to the degree of their metastasis
(Mimori et al., 2005; Takeda et al., 2007; Buim et al., 2010).
As gene expression profile during a physiological response to
a wound positively correlates with that in epithelial tumors
(Chang et al., 2005), it has been postulated that CD9 may be
involved in wound healing. In fact, CD9 has been reported to
have a role in keratinocyte motility, growth, or terminal
differentiation in vitro (Penas et al., 2000). Here, we
undertook the present study to investigate the role of CD9
in cutaneous wound healing using mice with genetic deletion
of CD9.
RESULTS
Expression of CD9 during wound healing in wild-type mice
CD9 was highly expressed in epidermis in normal skin
(day 0, Figure 1). Following wounding, it was markedly
downregulated in migrating epidermis (day 3 and 5, Figure 1).
When the wound was close to re-epithelialization, epidermal
CD9 was reelevated (day 7, Figure 1), and reached a level
comparable to that observed in normal skin epidermis when
re-epithelialization was fully completed (day 10, Figure 1).
CD9 was also expressed in endothelial cells, fibroblasts,
lymphocytes, and macrophages in granulation tissues
(Supplementary Figure S1 online). The downregulation of
CD9 in migrating epidermis may suggest that a lower level of
CD9, as compared with unwounded epidermis, is required
for the normal wound re-epithelialization.
Delayed wound healing in CD9-null mice
To determine directly the potential contribution of CD9 to
wound healing, CD9-null mice were used and their ability to
heal full-thickness dorsal excisional wounds was compared
with their corresponding wild-type littermates. Before the
experiments, the absence of CD9 expression in CD9-null
mice was confirmed at both protein and mRNA levels, and a
similar skin histoarchitecture was found in CD9-null mice
compared with their wild-type controls (Supplementary
Figure S2 online). Unexpectedly, wound healing in CD9-
null mice was delayed on day 5 and day 7 macroscopically
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Figure 1. Downregulation of CD9 in epidermis during wound healing in wild-type mice. Immunofluorescence staining of CD9 in normal unwounded skin
(day 0), day 3, day 5, day 7, and day 10 wound sections obtained from wild-type mice showing downregulation of CD9 in migrating epidermis during
normal wound re-epithelialization. Wounds were close to re-epithelialization on day 7 and fully re-epithelialized on day 10. K10 served as an internal control
as it is known to be downregulated in migrating epidermis during wound healing (Mathay et al., 2008; n¼ 6 wounds). Bar¼ 100mm. GT, granulation
tissue; WM, wound margin. Narrow-dotted line: interface between epidermis and dermis or leading edge of migrating epidermis (day 5). Wide-dotted line:
wound margin.
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(Figure 2a). On day 7 post wounding, 75% of wounds were
closed in wild-type controls, but none in CD9-null mice. We
further analyzed the histological samples of these wounds;
however, wound gaps remained significantly wider in CD9-
null wounds on day 5 and day 7 than in wild-type controls
(Figure 2b and c). These results revealed a healing delay in
CD9-null mice.
Impaired re-epithelialization responsible for healing delay in
CD9-null wounds
Both dermal contraction and re-epithelialization contribute
to wound healing. We compared the dermal gape, an index
for dermal contraction, and the length of migrating epidermis,
an index for re-epithelialization, between CD9-null and wild-
type wounds. No significant difference in dermal gape was
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Figure 2. Delayed wound healing and impaired re-epithelialization in CD9-null mice. (a, b) Macroscopic (a) and histological (b) comparison of wound
healing in CD9-null (knockout, KO) mice with wild-type (WT) controls at indicated time points. Arrows indicate the leading edges of epidermis.
Bar¼200 mm. (c–e) Summary of averaged wound gape (c), dermal gape (d), and length of migrating epidermis (e) over the course of healing.
Results are mean±SEM, n¼ 8–12 wounds; *Po0.01, #Po0.05 compared with WT controls; (f, g) keratinocyte proliferating cell nuclear antigen (PCNA)
staining (f) and the percentage of positive cells (g) at wound edge on day 5 post wounding. Bar¼ 250mm, n¼ 8. (h) Western blot results of PCNA expression
in day 5 wounds, n¼ 3.
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observed between the two strains of mice (Figure 2d). The
length of migrating epidermis, however, was significantly
reduced in CD9-null wounds, the level of which on day 3, 5,
and 7 post wounding was 105%, 71%, and 62% of that
measured in wild-type controls, respectively (Figure 2e),
indicating an impaired re-epithelialization in CD9-null
wounds. Re-epithelialization could be influenced by either
cell proliferation or migration. We determined the prolifera-
tion of keratinocytes in epidermis near the wound edge in
both strains of mice by counting the proliferating cell nuclear
antigen-positive immunostaining cell numbers, but no
significant difference was observed (Figure 2f and g). Western
blot results also showed a near level of proliferating cell
nuclear antigen in wound tissues from those mice (Figure 2h),
indicating that CD9 deficiency, as a whole, has no obvious
effect on the proliferation of cells participating in wound
healing. Taken together, these results suggested that epider-
mal migration is the process primarily affected by CD9
deficiency accounting for the impaired re-epithelialization in
CD9-null mice.
Enhanced activation of JNK in migrating epidermis from
CD9-null wounds
CD9 has been shown to couple several signaling pathways
including mitogen-activated protein kinases in various cell
types (Hemler, 2005). We hypothesized that CD9 deficiency
might perturb the intracellular signaling during wound
healing. In search of possible signaling pathway, we observed
a significantly increased phosphorylation of JNK in CD9-null
wounds, with no alteration to its protein level (Figure 3a).
We then compared the expression profile of phosphorylated
JNK between the two strains of mice at different time
points after wounding. Normal unwounded skin from both
strains of mice presented a similar low basal level of JNK
phosphorylation (Figure 3b and c). Following wounding,
phosphorylation of JNK in wild-type wounds moderately
increased by day 3, then returned to basal level from day 5;
however, a persistent enhanced phosphorylation of JNK was
observed in CD9-null wounds, the level of which on day 3, 5,
and 7 post wounding was 2.7-, 3.4-, and 2.4-fold higher than
those in wild-type controls, respectively (Figure 3b and c).
Immunostaining results showed that phospho-JNK staining
appeared mostly in epidermis in both strains of mice
regardless of the presence or absence of wounds (Figure
3d–g). Notably, a stronger staining was observed in migrating
epidermis from CD9-null wounds (Figure 3f and g). These
results allowed us to propose a possible relationship between
the abnormal JNK signaling that occurred on day 3 and the
healing delay that occurred on day 5 and 7 post wounding in
CD9-null mice.
Abnormal elevation of matrix metalloproteinase-9 paralleled by
enhanced JNK signaling in CD9-null wounds
JNK is able to activate the transcription of matrix metallo-
proteinase (MMP)-9/2 in cells including keratinocytes
(Yoshimura et al., 2005; Vincenti and Brinckerhoff, 2007;
Bahar-Shany et al., 2010). Because excessive MMP-9/2 has
an adverse role in chronic wound (Medina et al., 2005), we
hypothesized that an abnormality in MMPs may exist in CD9-
null wounds due to enhanced JNK signaling. Protein level
and enzyme activity of MMP-9 were analyzed by western
blot and gelatin zymography, respectively. MMP-9 expres-
sion was not detected in normal skin, but induced post-
wounding with elevated enzyme activity in both strains of
mice (Figure 4a and b). By day 7, MMP-9 decreased to basal
level in wild-type controls (Figure 4a and b), when wounds
were close to re-epithelialization as mentioned above. In
contrast, CD9-null wounds presented an abnormal elevation
of protein expression and enzyme activity of MMP-9 from
day 3 to day 7 (Figure 4a and b). Reverse transcription-PCR
results showed a higher level of MMP-9 mRNA in CD9-null
wounds (Figure 4c), indicating that abnormal elevation
of MMP-9 occurred at the transcription level. Consistent
with previous studies (Madlener et al., 1998; Lund et al.,
1999), we found that MMP-9 was expressed predominately
in migrating epidermis, and slightly in some of cells in
granulation tissues (Figure 4d). The staining of MMP-9
in CD9-null wounds, especially in the migrating epidermis,
was much stronger than that in wild-type controls (Figure 4d).
Here, a highly positive correlation was observed between
phospho-JNK and MMP-9 expression in CD9-null wounds
(r¼0.86, Po0.01). We also compared the profile of MMP-2
between the two strains of mice, but no difference was
detected except that of day 5 (Figure 4b and Supplementary
Figure S3 online).
Excessive degradation of type IV collagen at new basement
membrane in CD9-null wounds
The formation of a new basement membrane is essential for
keratinocyte migration during wound re-epithelialization. To
see whether hyper-elevated MMP-9 may adversely affect the
re-epithelialization process in CD9-null mice, we compared
the staining of type IV collagen, one of the major components
of basement membrane and substrates for MMP-9, in CD9-
null wounds with that in wild-type controls. In normal skin, a
near identical level of type IV collagen staining was
detected at the basement membrane from both strains of
mice (Figure 5a). After wounding, a gradual increase in the
deposition of type IV collagen at new basement membrane
was observed in wild-type wounds (Figure 5a, left panel).
Similar extent of collagen deposition, however, was absent in
CD9-null wounds on day 5 and day 7 (Figure 5a, right panel).
Western blotting results showed a significant decrease in type
IV collagen (160-kDa form) in CD9-null wounds compared
with wild-type samples (Figure 5b). This was accompanied
with an increase in the degraded fragment of type IV collagen
(the 40-kDa form) (Figure 5b). On day 5 and day 7 post
wounding, the ratio of type IV collagen degradation in
CD9-null wounds was 3.4- and 5.7-fold higher than that in
wild-type controls (Figure 5b). Local injection of MMP-9
inhibitor at a concentration of 50 mM daily suppressed
the degradation of type IV collagen in CD9-null wounds
(Figure 5c). These results provide evidence that the formation
of new basement membrane in CD9-null wounds was
impaired, due to the excessive degradation of type IV
collagen by MMP-9.
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Improved wound healing in CD9-null mice by JNK suppression
A recent study showed that exogenous MMP-9, at the level
found in chronic wounds, delayed wound healing
with diminished type IV collagen and impaired epithelial
migration (Reiss et al., 2009). We suspect that JNK suppression
may improve the healing of CD9-null wounds if the enhanced
epidermal JNK signaling is responsible for the hyper-elevated
MMP-9 in these mice. We tested this hypothesis by local
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Figure 3. Hyper-activation of C-JUN NH2 terminal kinase (JNK) in CD9-null wounds. (a) Representative western blot results showing increased JNK
phosphorylation on day 3 post wounding in knockout (KO) mice, with no alteration to its protein level. (b, c) Representative western blot results (b) and
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injection of SP600125, a specific inhibitor of JNK, in CD9-
null wounds. Administration of SP600125 at dosage of
3.0mM twice a day decreased JNK activity by 57%, with
reduction of MMP-9 expression and activity to levels
comparable to those observed in wild-type controls
(Figure 6a and b). To address whether SP600125 directly
inhibits JNK, and thus the production of MMP-9 in migrating
epidermis, we scraped CD9-deficient keratinocytes mono-
layer and pretreated the cells with or without SP600125.
Inhibition of JNK also reduced MMP-9 expression in vitro
(Figure 6c), confirming a critical role for JNK in the abnormal
elevation of MMP-9 in migrating epidermis in CD9-null mice.
Accordingly, significantly reduced degradation of type IV
collagen was observed in CD9-null wounds by SP600125
(Figure 6d). We then determined whether JNK suppression
could rescue the healing delay in CD9-null mice. Notably,
accelerated healing was observed on day 7 in SP600125-
treated CD9-null wounds (Figure 6e). This acceleration was
further confirmed by histological analysis (Figure 6f), with
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longer than those in DMSO-treated controls (Figure 6g).
These results thus demonstrated an adversary effect of over-
activation of JNK signaling, through upregulation of MMP-9,
in epidermal migration and wound re-epithelialization in
CD9-null mice.
DISCUSSION
Here, we have examined the role of CD9 in wound re-
epithelialization in vivo. Although downregulation of CD9 in
migrating epidermis may indicate a low level of CD9
beneficial for the normal healing process, CD9 is absolutely
required for normal wound re-epithelialization, as this
process is definitely delayed in CD9-null mice. We identified
that such delay is due to impaired epidermal migration. Our
data, to our knowledge, thus showed a previously unreported
physiological function of CD9 in wound healing in vivo.
JNK activity has been known upregulated in migrating
epidermis during wound re-epithelialization (Deng et al.,
2006); the factors controlling JNK activity, however, are
largely unclear. In this regard, cytokines, such as TNF-a and
transforming growth factor-b, and integrins and their ligands,
such as integrin a6b4 and lamin-5, are implicated to be the
candidates, as they activate JNK in keratinocytes in vitro
(Nguyen et al., 2000; Kadrmas et al., 2004; Seomun et al.,
2008; Bahar-Shany et al., 2010). In contrast to previous
findings, our in vivo study showed that JNK activity was
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significantly altered by CD9 deficiency, suggesting a pre-
viously unreported, CD9-mediated mechanism for the
regulation of JNK in migrating epidermis during wound
healing. JNK activation has been shown to be necessary for
keratinocyte migration and normal healing of epithelial or
skin wounds (Bosch et al., 2005; Deng et al., 2006). It has
therefore been suggested that augmenting JNK activity may
be used to accelerate wound closure (Gazel et al., 2006).
However, our current finding that decontrol of JNK by CD9
deficiency leads to a retarded re-epithelialization clearly
indicates that abnormally enhanced JNK activity is actually
detrimental to the healing process (Figure 6). A precise
regulation of JNK activity would thus be critical for the
normal wound re-epithelialization.
Restoration of basement membrane, controlled by a
precise dynamics of ECM, is a key step supporting
keratinocyte migration during wound re-epithelialization.
MMP-9 is believed to function in the remodeling of basement
membrane because several ECMs including type IV collagen
have been identified as the substrates for this protease. In an
acute wound, MMP-9 is transiently induced and has an
essential role in wound re-epithelialization (Kyriakides et al.,
2009). In contrast, abnormally high levels of MMP-9 are seen
in many chronic wound types, disturbing the balance
between ECM degradation and formation (Ladwig et al.,
2002; Ekekezie et al., 2004; Rayment et al., 2008).
Exogenous MMP-9, at the level found within chronic
wounds, has been shown to delay wound healing with
diminished type IV collagen and impaired epidermal migra-
tion (Reiss et al., 2009). These studies indicate that although
MMP-9 is required for normal wound healing, excessive
MMP-9 impairs the healing process definitely.
We observed an excessive production of MMP-9 through
epidermal JNK signaling in CD9-null wounds, indicating a
potential CD9-JNK-MMP-9 pathway in wound re-epitheliali-
zation. A similar role for CD9 to regulate MMP-9 has also
been observed previously (Hong et al., 2005). Our findings
also partially concur with a recent report that double
knockout of CD9 and CD81 alters lung macrophage motility
with elevated MMP-9 (Takeda et al., 2008). We further
showed that the elevated MMP-9 resulted in an over-
degradation of type IV collagen and impaired formation of
basement membrane in CD9-null wounds. These findings
therefore provided a reasonable explanation for the adverse
effects of the decontrolled JNK signaling by CD9 deficiency
on epidermal migration and wound re-epithelialization. The
similar features, excessive production of MMP-9 and over-
degradation of ECM, observed in both chronic wounds and
CD9-null wounds suggest that the disorder of CD9-regulated
JNK signaling might be implicated in the pathogenesis of
chronic wounds.
How does CD9 deficiency lead to enhanced JNK
signaling? Because of its short intracytoplasmic domains, it
is unlikely that CD9 interacts with JNK directly. CD9 is
known to form a complex with integrin a6, a3, a2, b1, and b4
in keratinocytes (Baudoux et al., 2000; Penas et al., 2000),
and can regulate the internalization, mRNA expression, and
membrane distribution of integrins (Furuya et al., 2005;
Ziyyat et al., 2006). As integrins are linked to the JNK
pathway (Nguyen et al., 2000), CD9 deficiency may disturb
the normal integrins complex and give rise to a disorder of
JNK signaling in migrating epidermis. We did find that the
mRNA levels of integrin b1 and an were significantly
increased, and that of integrin a6 decreased, in CD9-null
wounds (Supplementary Figure S4 online). Notably, MMP-9
could be upregulated by either integrin a3b1 (Iyer et al.,
2005) or anb6 in keratinocytes (Ridgway et al., 2005). These
findings enable us to propose that, in migrating epidermis
during wound re-epithelialization, integrins may provide a
link between CD9 and JNK, with MMP-9 production being
the final output of this signaling pathway (Supplementary
Figure S5 online). Further work is required to elucidate the
possible interaction of CD9 with integrins in JNK regulation
in vivo.
It should also be noted that although JNK suppression
reduced MMP-9 in CD9-null wounds to a level comparable
to that of wild-type controls (Figure 6), the wound-healing
process in JNK inhibitor-treated CD9-null mice and wild-type
controls were not the same. By day 7, only 30% wounds were
closed in JNK inhibitor-treated CD9-null wounds, whereas
75% wounds closed in wild-type controls (data not shown).
One possible explanation is that CD9 deficiency may alter
the function of other cells such as macrophages and
endothelial cells that are also involved in the healing process,
although fibroblasts infiltration was not affected by CD9
deficiency (Supplementary Figure S6 online).
In summary, the present study has revealed an important
role of CD9 in cutaneous wound healing, linking it directly to
basement membrane formation and epidermal migration
through controlling the epidermal JNK/MMP-9 pathway. As
excessive production of MMP-9 and over-degradation of
ECM have been implicated in both chronic wounds, and now
demonstrated in CD9-null wounds, we postulate that the
disorder of CD9-regulated JNK signaling could be a cause
underlying the pathogenesis of chronic wounds at the
molecular level. Such a model, if proven correct, will open
up the possibility to develop new treatment strategies for
chronic wounds.
MATERIALS AND METHODS
Mice
CD9-null mice (Miyado et al., 2000) were backcrossed more than
five generations into the C57BL/6J background. Mice were main-
tained in a barrier facility, and all animal procedures were performed
in accordance with the Chinese University of Hong Kong guidelines
on Animal Care. Female CD9-null mice (12- to 16-week-old) and
their wild-type littermates were used in this study.
Wound processing and morphological analysis
The dorsal skin of anaesthetized mice was shaved, and two full-
thickness excisional wounds were made per mice on both sides in
the middle of the dorsum using 3-mm biopsy punch. Wounds were
left uncovered and photographed at indicated time points. For
histological examination, wounds were collected and bisected along
the anterior–posterior axis of the skin and fixed in 4% formaldehyde
and then embedded in paraffin. Sections from the center were
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stained with hematoxylin and eosin. Wound gape was quantified by
measuring the distance between the leading edges of epidermis
across the wound bed. Dermal gape was determined by measuring
the distance between the dermal wound margins. Length of migrating
epidermis was calculated by adding together the lengths of the
newly formed epithelium from the leading edge of epidermis to both
sites of the wound margin. Visualization and definition of the above-
mentioned terms were showed in Supplementary Figure S7 online.
Subcutaneous injection of MMP-9 inhibitor or SP600125
To locally administer specific inhibitors of MMP-9 or JNK in
the wound vicinity, MMP-9 inhibitor (50mM daily, Calbiochem,
Darmstadt, Germany) or SP600125 (2 3.0mM daily, Calbiochem)
was injected subcutaneously with 40G syringe at four sites
around the wound, allowing the agents to infiltrate the wound
margins. Mock injections were given using phosphate-buffered
saline or DMSO vehicle. First injections were given on day 1 after
wounding, followed by further injections every day until wounds
were harvested.
Protein analysis: western blots, gelatin zymography, and
immunostaining
Normal skins or wound tissues containing both wound rim and
granulation tissues were powdered and homogenized in radio-
immunoprecipitation assay lysis buffer. Extracted protein was
separated by SDS-PAGE. To determine the expression levels of
protein, western blots were performed using commercially available
antibodies (Supplementary Methods online). To analyze the activ-
ities of MMP-9 and MMP-2 in wound tissues, gelatin zymography
was performed (Supplementary Methods online). To detect the
expression and cellular localization of proteins by immunostaining,
harvested wound tissues were embedded by paraffin or optimum
cutting temperature compound followed by snap-freezing. Immu-
noenzyme or immunofluorescence assay was performed using
commercially available antibodies in paraffin-embedded or fresh-
frozen sections (Supplementary Methods online). We also performed
an immunoenzyme staining for MMP-9 in cultured primary
keratinocytes from knockout mice (Supplementary Methods online).
Statistics
All values were expressed as mean±SD or mean±SEM. For
evaluation of statistical significance, two-tailed Student’s t-test or
analysis of variance was performed. Po0.05 was considered
statistically significant.
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